Ernexa Therapeutics (ERNAW) Capital Leases (2010 - 2022)

Ernexa Therapeutics (ERNAW) reported Capital Leases of $6000.0 for Q3 2022, up 50.0% quarter-over-quarter from $4000.0 in Q3 2020.

Ernexa Therapeutics (ERNAW) Capital Leases (2010 - 2022) Analysis & Trends

Ernexa Therapeutics has reported Capital Leases for 12 years, with the latest figure at $6000.0 in Q3 2022.

  • For the quarter ending Q3 2022, Capital Leases changed N/A year-over-year to $6000.0; the trailing twelve-month figure through Sep 2022 stood at $6000.0 (changed N/A YoY), and the FY2019 full-year result was $20000.0, down 51.22% from the prior year.
  • Capital Leases for Q3 2022 stood at $6000.0, up from $4000.0 in the prior quarter.
  • The five-year high for Capital Leases was $114000.0 in Q1 2018, with the low at $4000.0 in Q3 2020.
  • Historically, Capital Leases has averaged $37300.0 across 4 years, with a median of $28000.0 in 2019.
  • Annual changes were most pronounced in 2018 — Capital Leases plunged 48.18% — and 2020, when it slumped 84.0%.
  • Ernexa Therapeutics' Capital Leases stood at $41000.0 in 2018, then slumped by 51.22% to $20000.0 in 2019, then tumbled by 80.0% to $4000.0 in 2020, then jumped by 50.0% to $6000.0 in 2022.
  • The last three Capital Leases figures came in at $6000.0 (Q3 2022), $4000.0 (Q3 2020), and $15000.0 (Q1 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Ernexa Therapeutics - - -

Historic Data

Download Data
DateValue
Sep 30, 2022 6,000.00
Sep 30, 2020 4,000.00
Mar 31, 2020 15,000.00
Dec 31, 2019 20,000.00
Sep 30, 2019 25,000.00
Jun 30, 2019 31,000.00
Mar 31, 2019 36,000.00
Dec 31, 2018 41,000.00
Jun 30, 2018 81,000.00
Mar 31, 2018 114,000.00
Dec 31, 2017 164,000.00
Sep 30, 2017 142,000.00
Jun 30, 2017 181,000.00
Mar 31, 2017 220,000.00
Dec 31, 2016 259,000.00
Sep 30, 2016 295,000.00
Jun 30, 2016 120,000.00
Mar 31, 2016 138,000.00
Dec 31, 2015 138,000.00
Sep 30, 2015 122,000.00